Figure AI has crossed a critical manufacturing milestone, producing roughly 150 humanoid robots in April 2026 alone, according to production data shared by CEO Brett Adcock. This represents more units than the company manufactured during its entire three-year history combined, marking a decisive shift from prototype development to industrial-scale production.

How Is Figure Achieving This Production Acceleration?

The dramatic ramp-up stems from three interconnected factors that have converged to enable mass manufacturing. Figure's BotQ facility in California began transitioning to the Figure 03 model in February 2026, a robot specifically engineered for high-volume production rather than custom assembly. Unlike earlier iterations that relied on expensive CNC-machined parts, the Figure 03 uses die-casting and injection molding to reduce manufacturing costs by 90 percent.

• Hardware Design: The Figure 03 replaces precision-machined components with die-cast parts and injection-molded elements, dramatically lowering per-unit production costs and enabling faster assembly cycles.
• Production Facility Capacity: The BotQ facility achieved a production rate of one robot every 90 minutes by April 2026, providing the throughput necessary to sustain the 150-unit monthly output.
• Software Training Requirements: The company's Helix 02 architecture requires massive amounts of real-world data from identical robots to train its vision-based control system, creating a direct incentive to manufacture robots at scale.

The timing aligns precisely with Figure's stated goal of achieving 24/7 autonomous operations and complete supply chain independence by summer 2026. To reach that objective, the company needs a fleet large enough to generate the continuous feedback loop required for its machine learning systems to improve.

What Do These Numbers Tell Us About Figure's Competitive Position?

While 150 units per month represents a significant achievement for a startup, it is only the opening chapter of an ambitious expansion plan. Figure has publicly stated its intention to reach an initial capacity of 12,000 units annually, with a long-term target of 50,000 units per year. If the current trajectory holds, the company would need to increase production roughly 80-fold to meet its stated goals.

The production surge also reflects Figure's success in securing real-world deployment opportunities. BMW completed an 11-month pilot program at its Spartanburg, South Carolina facility, where a Figure 02 robot contributed to the production of approximately 30,000 BMW X3 SUVs. Based on this successful trial, BMW signed a formal commercial agreement with Figure AI to expand humanoid robot deployment across its manufacturing operations, signaling confidence in the technology's practical utility.

"Humanoid robots manufactured at Figure by month," stated Brett Adcock, CEO of Figure AI, when sharing the production chart that revealed the dramatic acceleration from research-level prototyping to industrial-scale manufacturing.

Brett Adcock, CEO at Figure AI

What Happens When Robots Outnumber Repair Capacity?

As Figure's fleet expands into the hundreds and thousands, a new operational challenge emerges: maintenance and repair logistics. The company recently unveiled Vulcan, an artificial intelligence-based balance policy that allows damaged robots to autonomously navigate to repair bays, even with multiple actuators or limbs non-functional. This capability becomes mathematically essential as production scales; without self-triage mechanisms, the Sunnyvale facility could quickly become overwhelmed with broken units awaiting repair.

The shift from "how do we build them?" to "how do we maintain them?" represents a fundamental transition in robotics manufacturing. Traditional industrial equipment manufacturers face similar challenges, but the complexity multiplies when the equipment itself is a general-purpose humanoid capable of learning and adapting to new environments.

Where Is Figure Deploying These Robots in Real Production?

BMW's commercial agreement represents the most concrete evidence of Figure's robots moving beyond pilot programs into genuine production environments. The Spartanburg pilot provided BMW with operational data on cycle times, placement accuracy, and the frequency of human worker intervention. Although neither company has disclosed specific performance metrics or cost savings, the fact that BMW moved from trial to a formal commercial contract suggests the robots met the automaker's internal benchmarks.

BMW is simultaneously deploying a different humanoid robot, called AEON, at its Leipzig facility in Germany. Developed in partnership with Hexagon Robotics, AEON is being deployed for high-voltage battery assembly and component manufacturing, tasks that are particularly labor-intensive and ergonomically demanding in electric vehicle production. This dual-platform approach suggests that BMW views humanoid robots not as a one-size-fits-all solution but as targeted tools for specific manufacturing challenges introduced by electrification.

The competitive landscape includes other major players testing humanoid robots in automotive manufacturing. Tesla has been experimenting with its Optimus robot in its own factories, Hyundai has access to Boston Dynamics' advanced bipedal hardware through its ownership stake, and Mercedes-Benz has run trials with Apollo robots from Apptronik. What distinguishes Figure's position as of April 2026 is the combination of a completed multi-month pilot with published vehicle-count data and a follow-on commercial contract.

What Remains Unknown About Figure's Manufacturing Economics?

Despite the impressive production numbers and real-world deployments, significant gaps remain in public understanding of the actual economic impact. BMW and Figure have not disclosed the dollar figures or cost-per-unit savings associated with the Spartanburg deployment, nor have they published the internal KPI frameworks that govern cycle time and accuracy. The 30,000-vehicle figure confirms that Figure 02 operated on a live production line, but it does not reveal how much labor cost was offset, how many human shifts were replaced, or whether error rates met BMW's internal targets.

The scope of BMW's commercial agreement remains partially undefined. Which vehicle models beyond the X3 will involve humanoid robots, how many units BMW plans to deploy, and what timeline governs each milestone all remain undisclosed. Whether the deal extends beyond Spartanburg to other BMW plants in the United States or elsewhere has not been confirmed. Labor impact data is similarly sparse; neither BMW nor any independent research body has published information on how humanoid adoption affects headcount, job categories, or retraining programs at the facilities where they operate.

The next meaningful signals will emerge when BMW either expands the Spartanburg deployment to additional vehicle lines or releases performance data from Leipzig's battery-assembly trials. Investors and industry analysts will also be watching for any mention of humanoid-robot economics in BMW's quarterly earnings calls; so far, the company has kept the topic in its manufacturing communications rather than its financial disclosures. For workers on the plant floor, the more immediate question is whether these robots create new technical roles, such as robot supervisors and maintenance specialists, fast enough to offset any positions they absorb.